Dr. Xiaolei Wang 王晓雷
Chief Physician
Department of Head and Neck Surgery, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of thyroid cancer, including recurrent cases involving the larynx, trachea, and esophagus with functional reconstruction. Also focuses on function-preserving surgery for hypopharyngeal and laryngeal cancer, and surgical management of cervical lymph node metastases.
Dr. Wang graduated from China Medical University in 1992 and received a doctoral degree from Peking Union Medical College in 2001. Specializing in head and neck tumor surgery, Dr. Wang performs combined radical surgeries and comprehensive treatments for common head and neck tumors. Research focuses on function-preserving surgery for laryngeal and hypopharyngeal cancer, and surgical and comprehensive treatment of cervical lymph node metastases.
Professional roles
- Standing Committee Member, Head and Neck Oncology Professional Committee, China Anti-Cancer Association
- Standing Committee Member, Thyroid Professional Committee, China International Exchange and Promotion Association for Medical and Healthcare
- Standing Committee Member, Head and Neck Oncology Group, Beijing Branch, Chinese Society for Radiation Oncology
- Standing Committee Member, Head and Neck Oncology Professional Committee, China Medical Education Association
Name order: in Chinese the family name comes first (Wang Xiaolei). Papers usually list the name as Xiaolei Wang or Wang X.
Selected publications
70 papers on PubMed matched by name and affiliation; 12 as first or senior author since 2016. Most recent first- or senior-author papers:
- Oncology, 2025 (senior author): High Expression of Cancer-Derived Sialylated Immunoglobulin G: A Novel Biomarker for Poor Prognosis in Laryngeal Squamous Cell Carcinoma. PubMed 39134010
- Discov Oncol, 2024 (senior author): Hsa_circYARS interacts with miR-29a-3p to up-regulate IREB2 and promote laryngeal squamous cell carcinoma progression. PubMed 39225900
- J Gene Med, 2024 (senior author): Natural killer cell-based signature: Prognostic analysis in head and neck squamous cell carcinoma. PubMed 38384136
- Front Immunol, 2023 (senior author): Efficacy and safety of pembrolizumab with preoperative neoadjuvant chemotherapy in patients with resectable locally advanced head and neck squamous cell carcinomas. PubMed 37583698
- Asian J Surg, 2022 (senior author): Isthmectomy is effective and sufficient for selected patients with the isthmus-confined solitary papillary thyroid carcinoma. PubMed 35181211
- Ann Transl Med, 2022 (senior author): Complications and oncological outcomes after salvage surgery for recurrent and residual hypopharyngeal squamous cell carcinoma: a retrospective cohort study. PubMed 35928744
- Surgery, 2022 (senior author): Surgical management of parapharyngeal lymph node metastases from thyroid carcinoma with transcervical approach. PubMed 34711428
- World J Clin Cases, 2021 (senior author): Local random flaps for cervical circumferential defect or tracheoesophageal fistula reconstruction after failed gastric pull-up: Two case reports. PubMed 34904107
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion